Get all your news in one place.
100's of premium titles.
One app.
Start reading
Manchester Evening News
Manchester Evening News
National
Jessica Sansome

Moderna coronavirus vaccine authorised for 12 to 17-year-old's in the UK by MHRA

The Moderna coronavirus vaccine has been authorised for people in the UK aged between 12 and 17.

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed the news today (Tuesday).

It comes as all young people aged 16 to 17, clinically vulnerable children aged 12 to 15 and people who live with adults who are immunosuppressed will be offered a first dose of a Pfizer jab within the next week.

The regulator said it is up to the Joint Committee on Vaccination and Immunisation to advise the government on whether children in this age group should be given the Moderna jab.

READ MORE:

Dr June Raine, MHRA chief executive, said: "I am pleased to confirm that that the Covid-19 vaccine made by Moderna has now been authorised in 12 to 17-year-olds. The vaccine is safe and effective in this age group.

"We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved Covid-19 vaccines and this surveillance will include the 12 to 17-year age group.

"It is for the Joint Committee on Vaccination and Immunisation (JCVI) to advise on whether this age group should be vaccinated with the Covid-19 vaccine made by Moderna as part of the deployment programme."

What do you think of the decision? Have your say in our comments

The Moderna COVID-19 vaccine (AP)

The Department of Health has asked the Joint Committee on Vaccination and Immunisation for a formal recommendation on whether to give the Moderna jab to 12 to 17-year-olds.

A spokesperson for the department said: "We welcome the news that Moderna’s vaccine has been approved as safe and effective for people aged 12 and over.

"As has been the case with all other approvals, we will now be guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) and have asked for its formal recommendation on whether to administer this vaccine to people aged 12 to 17.

"All young people aged 16 to 17, clinically vulnerable children aged 12 to 15 and people who live with adults who are immunosuppressed will be offered a first dose of a Pfizer jab by Monday 23 August."

The Moderna vaccine became the third to be approved in the UK at the start of the year in addition to the the Pfizer/BioNTech and AstraZeneca jabs.

To get the latest email updates from the Manchester Evening News, click here.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.